Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|January 28, 2022
Multi-target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives against Influenza VirusesEdeildo Ferreira da Silva-Júnior, Leandro Rocha SilvaCurrent Medicinal Chemistry|March 15, 2021
Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural ProductsLeandro Rocha Silva, Edeildo Ferreira da Silva-JúniorAdvances in Protein Chemistry and Structural Biology|May 5, 2025
Exploring therapeutic strategies based on chaperon-mediated disaggregationLeandro Rocha Silva, Sheila Oliveira de Souza, Ana Catarina Rezende Leite, et al.Bioorganic & Medicinal Chemistry Letters|August 27, 2022
Nitro compounds against trypanosomatidae parasites: Heroes or villains?Paulo Fernando da Silva Santos-Júnior, Leandro Rocha Silva, Lucindo José Quintans-Júnior, et al.Current Medicinal Chemistry|April 20, 2023
Natural Coumarin Derivatives Targeting MelanomaLeandro Rocha Silva, Jéssica Alves Nunes, Peng Zhan, et al.Advances in Protein Chemistry and Structural Biology|May 23, 2026
Aptamers as immunomodulatory therapeutic alternatives targeting neglected tropical diseases (NTDs)Leandro Rocha Silva, Wadja Feitosa Dos Santos Silva, Ana Clara Ferreira de Melo, et al.Current Medicinal Chemistry|June 24, 2021
Targeting Chikungunya Virus Entry: Alternatives for New Inhibitors in Drug DiscoveryLeandro Rocha Silva, Érica Erlanny da Silva Rodrigues, Jamile Taniele-Silva, et al.Bioorganic & Medicinal Chemistry|May 16, 2021
Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteasesLeandro Rocha Silva, Ari Souza Guimarães, Jadiely do Nascimento, et al.Bioorganic & Medicinal Chemistry|October 2, 2020
Druggable targets from coronaviruses for designing new antiviral drugsLeandro Rocha Silva, Paulo Fernando da Silva Santos-Júnior, Júlia de Andrade Brandão, et al.Advances in Protein Chemistry and Structural Biology|May 23, 2026
Peptides and peptidomimetics as immunomodulator agents targeting neglected tropical diseasesSheila Oliveira de Souza, Leandro Rocha Silva, Manuele Figueiredo da Silva, et al.Pageof 2